| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. (AMPH) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AMPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.00M | $59.22M | - | |
| CFO | 177.0K | $3.49M | - | |
| VP | 172.8K | $3.41M | - | |
| VP | 122.9K | $2.43M | - | |
| Dir | 71.4K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.73 | $147,219.09 | -24.6% | |
| Oct 5, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sale+OE | 8,444 | $18.87 | $159,376.28 | -19.7% | |
| Oct 4, 2017 | Petersen Floyd F.51 | Director | Sale+OE | 39,312 | $18.59 | $730,755.04 | -37.8% | |
| Oct 2, 2017 | Zasloff Michael A53 | Director | Sale+OE | 63,624 | $18.18 | $1,156,951.54 | -62.5% | |
| Aug 15, 2017 | Prins Richard K61 | Director | Sale+OE | 10,000 | $14.81 | $148,084.00 | -14.8% | |
| Jun 9, 2017 | Prins Richard K61 | Director | Sale+OE | 10,000 | $17.07 | $170,707.00 | -25.7% | |
| Jun 1, 2017 | Zasloff Michael A53 | Director | Sale+OE | 15,000 | $17.01 | $255,201.00 | -31.6% | |
| May 31, 2017 | Shandell Jason B. | President And General Counsel | Sell | 11,482 | $16.92 | $194,300.39 | -2.3% | |
| May 30, 2017 | Peters William J52 | CFO, SVP &Treasurer | Sell | 4,297 | $16.93 | $72,730.59 | -4.7% | |
| May 11, 2017 | Prins Richard K61 | Director | Sale+OE | 7,500 | $15.43 | $115,725.00 | -24.6% |